about
Dysbiosis in inflammatory bowel diseaseAutoantibodies and an immune-based rat model of inflammatory bowel diseaseChemically defined diet alters the protective properties of fructo-oligosaccharides and isomalto-oligosaccharides in HLA-B27 transgenic ratsGut Microbiota and Complications of Liver Disease.In Vivo and In Vitro Study on the Efficacy of Terpinen-4-ol in Dextran Sulfate Sodium-Induced Mice Experimental Colitis.Confocal laser endomicroscopy is a new imaging modality for recognition of intramucosal bacteria in inflammatory bowel disease in vivo.TLR2 and interleukin-10 are involved in Bacteroides fragilis-mediated prevention of DSS-induced colitis in gnotobiotic mice.Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models.Adherent-invasive Escherichia coli in inflammatory bowel disease.Quantification of intestinal bacterial populations by real-time PCR with a universal primer set and minor groove binder probes: a global approach to the enteric flora.Effect of salicin on gut inflammation and on selected groups of gut microbiota in dextran sodium sulfate induced mouse model of colitis.Commensal Escherichia coli reduces epithelial apoptosis through IFN-alphaA-mediated induction of guanylate binding protein-1 in human and murine models of developing intestine.Helicobacter species in the intestinal mucosa of patients with ulcerative colitis.Human lymphocyte stimulation with pouchitis flora is greater than with flora from a healthy pouch but is suppressed by metronidazole.Patterns of Antibiotic Exposure and Clinical Disease Activity in Inflammatory Bowel Disease: A 4-year Prospective Study.Reduced mucosal antimicrobial activity in Crohn's disease of the colon.The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review.Effectiveness of Saccharomyces boulardii in a rat model of colitisThe intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?Use of antibiotics in the treatment of inflammatory bowel disease.Role of bacteria in the etiopathogenesis of inflammatory bowel diseaseHelicobacter pylori and Crohn's disease: a retrospective single-center study from ChinaRecent advances and remaining gaps in our knowledge of associations between gut microbiota and human healthUtility of the Nonabsorbed (<0.4%) Antibiotic Rifaximin in Gastroenterology and Hepatology.Could Helicobacter organisms cause inflammatory bowel disease?Diet in inflammatory bowel disease.Proteomics at the interface of psychology, gut physiology and dysfunction: an underexploited approach that deserves expansion.Biological pathways involved in the development of inflammatory bowel disease.Epithelia under metabolic stress perceive commensal bacteria as a threat.Mouse models of intestinal inflammation and cancer.Relationships between inflammatory bowel disease and perinatal factors: both maternal and paternal disease are related to preterm birth of offspring.Kefir treatment ameliorates dextran sulfate sodium-induced colitis in rats.Isolation of Helicobacter pylori from the intestinal mucosa of patients with Crohn's disease.Alpha-Tocopheryl Succinate-Conjugated G5 PAMAM Dendrimer Enables Effective Inhibition of Ulcerative Colitis.Involvement of gut microbiome in human health and disease: brief overview, knowledge gaps and research opportunities.Preterm birth but not mode of delivery is associated with an increased risk of developing inflammatory bowel disease later in life.Contribution of polymeric immunoglobulin receptor to regulation of intestinal inflammation in dextran sulfate sodium-induced colitis.[Dipeptidyl peptidase IV in inflammatory bowel diseases (DPP IV/CD26)].Toll-like receptor 2 monoclonal antibody or/and Toll-like receptor 4 monoclonal antibody increase counts of Lactobacilli and Bifidobacteria in dextran sulfate sodium-induced colitis in mice.Crohn's disease-associated Escherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin.
P2860
Q24685931-01633224-141B-4C5E-80D1-02C0F93FE114Q26822756-C225FC08-902D-4FBE-91DC-49117A468476Q27332418-3A684B8C-8112-4585-98FE-A901B3398039Q30236024-1BF94769-DA1E-4777-B988-C72EB56A2188Q33665405-70A708A7-2921-4A45-B784-282C6AF4B9E2Q33730054-6E75AE60-FB09-430F-B3AD-15034234209AQ33880555-4F5A39F6-932F-4A5C-9334-0C8DE305D732Q33886458-914B9AF3-CE39-49E3-8501-06BABF3BD646Q34625186-FB9AE63D-7932-4E39-9154-89D40CD4179CQ34780290-A98A9EBA-DE53-4050-B16C-4A9CD5DC7E8CQ35044865-D9739CC5-226C-4725-85D3-BB9D07DC6F19Q35132878-7AC1804B-284F-4729-9141-D4E662719012Q35553111-3277C591-1098-42D4-A2B9-05337C520DFCQ35597016-64DCFCC8-D2FD-4EB4-B4FA-6B9D5A4D48A0Q35752421-DD914A0B-2418-4091-8EE1-B56698D27DE2Q35954105-F6D1CABF-C7A9-49E3-81A1-F11E4E959AA1Q36153323-0FE9D49F-0670-4340-8F2E-A8D52140B530Q36429838-04066DAF-7CB3-414D-B661-1BCDED2F0C24Q36515597-D624B792-6197-43EB-9682-9C2C97B141ABQ36521201-CBD5B6DE-FFD3-4626-AA3D-977296BE3FCEQ36975929-782BE8E2-3A64-44F1-A91F-AFCA8E6EC0C4Q37050515-0138C58F-32A2-4801-835E-DF13CCAE11CDQ37122143-BC65CB30-A55C-4D1E-9885-64C0F2ABED1AQ37678916-D9FC663A-8B9E-4368-BB89-5B18BE970160Q37801005-EAAB142F-3B56-41F4-BF1C-2BC9CDBE970CQ37859176-BD1403A6-4E68-441D-8BFF-8195AA805E90Q37945789-58C6A8C2-3B8E-4A2C-B10F-D87A3A790186Q38254327-4B67F77B-855B-4A14-801A-D07D31E50648Q38722151-068B9713-BCFA-45DD-A85B-73AE59B505CBQ38867429-78E15664-B077-4BB6-85A4-EBCCC537812DQ39942595-F3225C26-1EA1-4EB9-9C14-62BD0C595332Q42004558-C78BB22D-CDEB-4F05-95A6-BE7FCD3012B2Q44281958-A7B5781A-548C-47F2-B64B-F79FBFC9F953Q46371480-D61A2A0D-6633-422A-98CD-6F2D065F1012Q49207471-3C596B57-60CE-42AC-9C1B-DD8CD42A8E46Q51750282-09F5B005-FC1C-4A43-A440-F5E594621063Q52572884-ABE0E2C4-B183-4072-B0D9-5E89FF67C264Q53807699-2E2AE907-47F5-4557-B2F6-56253BAFC376Q54358058-28863932-4C3B-4599-8125-DBD96B59AB3EQ54425261-7025D4E5-93AD-45CF-BEDB-182B82328C15
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Microbial factors in inflammatory bowel disease.
@ast
Microbial factors in inflammatory bowel disease.
@en
Microbial factors in inflammatory bowel disease.
@nl
type
label
Microbial factors in inflammatory bowel disease.
@ast
Microbial factors in inflammatory bowel disease.
@en
Microbial factors in inflammatory bowel disease.
@nl
prefLabel
Microbial factors in inflammatory bowel disease.
@ast
Microbial factors in inflammatory bowel disease.
@en
Microbial factors in inflammatory bowel disease.
@nl
P1476
Microbial factors in inflammatory bowel disease.
@en
P2093
J Thomas LaMont
Richard J Farrell
P356
10.1016/S0889-8553(01)00004-8
P577
2002-03-01T00:00:00Z